[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584989":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":7,"responsibleParty":21,"collaborators":7,"id":23,"slug":24,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":27,"acronym":28,"eligibilityCriteria":29,"healthyVolunteers":25,"sex":30,"minAge":7,"maxAge":31,"enrollmentInfo":32,"targetDuration":31,"studyType":35,"phases":7,"briefSummary":36,"conditions":37,"keywords":44,"overallStatus":46,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":7},{"fullName":5,"class":6},"Precia Group","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Donna Russell, MPA","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","12069922825","donna.russell@preciagroup.com",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Samantha Udondem, MPH","9403431959","samantha.udondem@preciagroup.com",{"type":22,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100584989","comprehensive-outcomes-monitoring-for-peri--and-postnatal-invasive-group-b-strep-sequelae-comppass-registry-100584989",false,"NCT06896526","Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry","COMPPASS","Inclusion Criteria:\n\n1. A child below the age of 19 who was either diagnosed with or received a lab test result confirming an iGBS infection, or being able to describe their child's condition and experience with iGBS infection at, or within 90 days of, birth.\n\n   or A child who was diagnosed as having invasive Group B Strep infection within the first 90 days after delivery and later passed away because of the infection or Parent who has experienced a stillbirth due to iGBS infection\n2. A sibling(s) from a multi-gestation pregnancy where at least one child was diagnosed as having invasive Group B Strep infection\n3. Parent or caregiver who understands and electronically signs the inform consent document\n4. In addition to parental or caregiver consent, children between the ages of 13-17 years who are able to understand and provide assent to take part in the study, as confirmed by an electronic signature by their consenting parent or caregiver.\n\nExclusion Criteria:\n\n1\\. A child affected by iGBS infection currently over the age of 18.","ALL","18 Years",{"count":33,"type":34},10000,"ESTIMATED","OBSERVATIONAL","The goal of this registry is to collect and store important medical and non-health information on children from 0 to 18 years of age affected by early- (up to 24 hours after birth) and late-onset (up to 90 days after birth) invasive Group B Streptococcus (iGBS) and their families. Data collected from families of children affected by perinatal iGBS will support further research to understand the short- and long-term impact of iGBS disease on affected children and its impact on their families. Participants will be invited to complete obstetric and pregnancy-related questionnaires as well as validated neurodevelopmental surveys at various timepoints throughout their participation in the registry.",[38,39,40,41,42,43],"Invasive Group B Streptococcus Disease","Group B Streptococcus","Group B Streptococcal Infection","Group B Streptococcus (GBS) Disease","Group B Streptococcal Infection, Early-Onset","Group B Streptococcal Infection, Late-Onset",[38,45],"Invasive Group B Streptococcus Registry","NOT_YET_RECRUITING","2025-03-19",{"date":49,"type":50},"2025-03-26","ACTUAL",{"date":52,"type":34},"2025-04-01",{"date":54,"type":34},"2035-03-31",{"name":5,"class":6}]